- Theoretical Exposition of Chronically treated patients to LLA2002 | Publication without faculty affiliation
- Use of hypolipidemic agents in patients before inclusion to ATLET study2007 | Faculty of Pharmacy in Hradec Králové
- Antihypertensive and hypolipidemic drug in one tablet2008 | First Faculty of Medicine
- Torcetrapib - new hypolipidemic drug2006 | First Faculty of Medicine
- Bioactive compounds of Lion's mane mushroom (Hericium Erinaceus)2014 | Publication without faculty affiliation
- Alirocumab, Praluent: Clinical studies: An overwiev2016 | First Faculty of Medicine
- Low HDL-cholesterol syndrome and the renesance of nicotinic acid2009 | Central Library of Charles University
- Low HDL-cholesterol syndrome and the renesance of nicotinic acid2009 | Faculty of Medicine in Pilsen
- Low HDL-cholesterol syndrome and the renesance of nicotinic acid2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Zoletorv - Pharmacological profile2017 | Faculty of Medicine in Pilsen
- Ezetimib, jeho účinky a uplatnění v léčbě dyslipidemií2017 | Faculty of Medicine in Pilsen
- Lipid lowering therapy - proven treatment options and prospects for the near future2022 | First Faculty of Medicine
- Proč tak málo využíváme kombinaci ezetimibu se statinem? Je čas pro akci!2019 | First Faculty of Medicine
- Kyselina bempedová, novinka mezi hypolipidemiky - co můžeme očekávat?2023 | First Faculty of Medicine
- Evolocumab, proproteine convertase subtilisin/kexin type 9 inhibitor for intensive treatment of dyslipidemia2016 | Faculty of Medicine in Pilsen
- Fixní kombinace v hypolipidemické léčbě2020 | First Faculty of Medicine
- Analysis of Nicotinic Acid and Its Metabolites by HPLC-MS/MS2015 | First Faculty of Medicine
- Euvascor - early intervention of hypertension and dyslipidaemia (dual combination of atorvastatin and perindopril)2020 | First Faculty of Medicine
- Ezetimibe and combination of lipid lowering medications: what is their role in the era of PCSK9 inhibitors?2017 | First Faculty of Medicine